Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 diabetes may face an overlooked risk: nutritional deficiencies. A new study found that nearly 1 in 6 young patients developed a diagnosed deficiency within a year of starting treatment, with vitamin D deficiency affecting about 12%.
❓ Unknown
Nutritional Deficiencies Linked to GLP-1 Weight Loss and Diabetes Drugs in Children
Just now
September 24, 2026
1 min read
📰 ScienceDaily Health
📋 Key Takeaway
A study revealed that nearly 1 in 6 children using GLP-1 medications for weight loss or diabetes developed nutritional deficiencies, particularly vitamin D deficiency. This finding raises concerns about the health implications for young patients in Iran, where obesity and diabetes are growing issues. Addressing these deficiencies is crucial for public health policy in the country.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
15 min ago •
More REM Sleep Linked to Lower Risk of 83 Diseases
33 min ago •
The Impact of Social Media on Body Image Ideals Among Young Women
41 min ago •
Israeli Bulldozers Destroy Palestinian Olive Groves Ahead of Harvest
42 min ago •
Spanish PM Sanchez Warns of Rising Far-Right Threat in UNGA Address
43 min ago •